Led by Professor Martin Hegner, Principal Investigator in CRANN and Trinity College Dublin’s School of Physics, the team’s specific quantitative assay enables direct classification of variant binding properties for screening emerging variants.
The major advantage of the newly developed nano technique with respect to (existing, commonly used) ELISA tests is that while it is equally sensitive – with added single amino-acid resolution – and able to directly detect multiple variants by in situ differential analysis, it can also do so in a mere fraction of the time.
The publication has been chosen by the publishing journal Nanoscale Advances for inclusion in the 2021 Popular Advance Collection.